COVID-19 Antibodies Among Healthcare Workers
NCT04425889 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 156
Last updated 2020-06-12
Summary
Observational, point of prevalence study determining the presence of anti-SARS-CoV-2 antibody
Conditions
- COVID-19
- SARS-CoV 2
Interventions
- DIAGNOSTIC_TEST
-
COVID-19 IgG/IgM Rapid Test Cassette test (Healgen Scientific, Houston, Texas, USA)
a blood sample is drained for detection of IgG and IgM antibody
Sponsors & Collaborators
-
Hospital Universitario Dr. Jose E. Gonzalez
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-05-05
- Primary Completion
- 2020-05-30
- Completion
- 2020-06-01
Countries
- Mexico
Study Locations
More Related Trials
-
SARS-CoV-2 IgG and IgM Serologic Assays
NCT04562246 ·Status: COMPLETED
-
Neutralizing Antibody Level After COVID-19 Vaccination
NCT05083026 ·Status: RECRUITING
-
Antibody Detection in COVID-19 Cured Patients (SARS-CoV-2-CZ-Immunity)
NCT04453280 ·Status: COMPLETED
-
Immune Status SARS-CoV-2 in a Sample of a Tertiary Eye Health Centre
NCT04446338 ·Status: UNKNOWN
-
COVID-19 IgG Antibodies in the Serum of Recovered Patients
NCT04470414 ·Status: UNKNOWN
-
Antibodies and Immunity After Vaccination of Recovered Patients With COVID-19 and Long COVID-19 Symptoms
NCT05484700 ·Status: UNKNOWN
-
Humoral Immunity Against SARS-CoV-2 in Liver Transplanted Patients After COVID-19 in Comparison With Immunocompetent Patients
NCT04410471 ·Status: UNKNOWN
-
HSS Covid-19 Antibody Serology Among Surgeons & Anesthesiologists
NCT04389294 ·Status: COMPLETED ·Phase: NA
-
A Single-center, Interventional Diagnostic Study With Minimal Risks and Constraints, Aimed at Longitudinally Evaluating Serum Antibody Levels in Patients With COVID-19 According to the Severity of Their Symptoms.
NCT06862531 ·Status: COMPLETED ·Phase: NA
-
Study to Find the Percentage of Cases Retaining COVID-19 IgG Antibodies 45-65 After They Have Tested Positive
NCT04605952 ·Status: COMPLETED
-
Prospective Assay for SARS-CoV-2 (COVID-19) Antibody Detection Indirectly by Immunofluorescence: SARS-CoV2 IIF Method
NCT04429620 ·Status: UNKNOWN
-
Prevalence and Clinical Significance of Anti-annexin A2 Antibodies in COVID-19 Infection
NCT05242159 ·Status: UNKNOWN
-
Prevalence of COVID-19 Antibodies Kingman AZ
NCT04533360 ·Status: COMPLETED
-
Are SARS-CoV-2 Specific Antibodies a Correlate for Protection?
NCT04469634 ·Status: COMPLETED ·Phase: NA
-
Waxing and Waning of Serum SARS CoV-2-IgG Level in COVID-19 Exposed Population
NCT04568850 ·Status: UNKNOWN
-
Monitoring the IgG/IgM Antibodies in COVID-19 Patients
NCT04810117 ·Status: COMPLETED
-
COVID-19 Antibody and Reinfection Study
NCT05365750 ·Status: COMPLETED
-
Understanding the Determinants of Mucosal Immunity and Optimizing the Diagnosis of Infection With SARS-CoV-2 Variants
NCT05858502 ·Status: RECRUITING ·Phase: NA
-
Persistence of Neutralizing Antibodies 6 and 12 Months After a Covid-19
NCT04543006 ·Status: UNKNOWN ·Phase: NA
-
Seroconversion in COVID-19 Recovered Population
NCT04558385 ·Status: COMPLETED
-
Seroprevalence of IgG Antibodies to SARS-CoV-2 (COVID-19) in Primary Health Care Workers and Their Household Contacts
NCT04808986 ·Status: COMPLETED ·Phase: NA
-
Effect of IMMUNEPOTENT-CRP on Serum Pro-Inflammatory Cytokines in Mild to Moderate COVID-19
NCT06676709 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Dynamics of the Immune Response to COVID-19 / Infection by SARS-CoV-2
NCT04655521 ·Status: COMPLETED
-
Antibody Response Against SARS-CoV-2 in Dialysis Patients During COVID-19
NCT04367714 ·Status: UNKNOWN
-
Evaluating the Response of the Immune System of People with Long COVID (post SARS-CoV-2)
NCT05131594 ·Status: ENROLLING_BY_INVITATION